Previous close | 2.4400 |
Open | 2.5000 |
Bid | 2.4300 x 300 |
Ask | 2.4700 x 200 |
Day's range | 2.4300 - 2.5000 |
52-week range | 1.8800 - 7.0600 |
Volume | |
Avg. volume | 352,520 |
Market cap | 121.49M |
Beta (5Y monthly) | 1.34 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.4200 |
Earnings date | 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 6.00 |
MARLBOROUGH, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the second quarter of 2024 after the market closes on Monday, August 5, 2024. Company management will host a conference call to discuss financial results at 5:00 p.m. ET. Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day i
Key Insights Akoya Biosciences' significant private equity firms ownership suggests that the key decisions are...
Key Insights Akoya Biosciences will host its Annual General Meeting on 4th of June Salary of US$542.5k is part of CEO...